Treasury Department Drafts Narrower Restrictions for U.S. Pharma Investments in China

By Ed Silverman · STAT News · 2026-09-18

According to reporting from STAT News, the U.S. Treasury Department is developing new regulations that would permit domestic pharmaceutical firms to maintain most licensing agreements with Chinese drug developers. These rules appear to carve out an exception for the life sciences

According to reporting from STAT News, the U.S. Treasury Department is developing new regulations that would permit domestic pharmaceutical firms to maintain most licensing agreements with Chinese drug developers. These rules appear to carve out an exception for the life sciences